Background
head and neck squamous cell carcinomas
Edited by: Shao Hui Huang, University Health Network, CanadaReviewed by: Mohamed Rahouma, Weill Cornell Medical Center, United States; Ali-Farid Safi, Craniologicum - Center for Craniomaxillofacial Surgery, SwitzerlandThis study aimed to explore the efficacy and safety of pembrolizumab combined with chemotherapy as neoadjuvant therapy in patients with resectable locally advanced head and neck squamous cell carcinomas (LA-HNSCCs).